Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

ClinicalTrials.gov ID: NCT01576718

Public ClinicalTrials.gov record NCT01576718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fp Spiromax® (Fluticasone Propionate Inhalation Powder) Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Severe Persistent Asthma Uncontrolled on High Dose Inhaled Corticosteroid Therapy

Study identification

NCT ID
NCT01576718
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Industry
Enrollment
889 participants

Conditions and interventions

Conditions

Interventions

  • Fp MDPI Drug
  • Placebo MDPI Other
  • Flovent Diskus Drug
  • albuterol/salbutamol Drug

Drug · Other

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2012
Primary completion
Jun 30, 2013
Completion
Sep 30, 2013
Last update posted
May 7, 2018

2012 – 2013

United States locations

U.S. sites
148
U.S. states
35
U.S. cities
117
Facility City State ZIP Site status
Teva Investigational Site 10504 Birmingham Alabama
Teva Investigational Site 10565 Homewood Alabama
Teva Investigational Site 11527 Goodyear Arizona
Teva Investigational Site 10516 Tucson Arizona
Teva Investigational Site 10573 Bakersfield California
Teva Investigational Site 11518 Costa Mesa California
Teva Investigational Site 10590 Fountain Valley California
Teva Investigational Site 10551 Granada Hills California
Teva Investigational Site 11520 Huntington Beach California
Teva Investigational Site 11545 Huntington Beach California
Teva Investigational Site 10547 Long Beach California
Teva Investigational Site 11549 Los Angeles California
Teva Investigational Site 10503 Mission Viejo California
Teva Investigational Site 10536 Newport Beach California
Teva Investigational Site 10540 Orange California
Teva Investigational Site 11551 Orange California
Teva Investigational Site 10578 Palmdale California
Teva Investigational Site 10585 Redwood City California
Teva Investigational Site 11538 Rolling Hills Estates California
Teva Investigational Site 11522 Roseville California
Teva Investigational Site 10582 San Diego California
Teva Investigational Site 11554 San Diego California
Teva Investigational Site 10563 San Jose California
Teva Investigational Site 11556 Santa Monica California
Teva Investigational Site 10506 Stockton California
Teva Investigational Site 10529 Walnut Creek California
Teva Investigational Site 10545 Centennial Colorado
Teva Investigational Site 10572 Colorado Springs Colorado
Teva Investigational Site 10533 Denver Colorado
Teva Investigational Site 11531 Denver Colorado
Teva Investigational Site 11542 Denver Colorado
Teva Investigational Site 11569 Wheat Ridge Colorado
Teva Investigational Site 10528 Waterbury Connecticut
Teva Investigational Site 10556 Boynton Beach Florida
Teva Investigational Site 11513 Brandon Florida
Teva Investigational Site 11507 Clearwater Florida
Teva Investigational Site 11546 Fort Myers Florida
Teva Investigational Site 11526 Hialeah Florida
Teva Investigational Site 11525 Kissimmee Florida
Teva Investigational Site 10537 Miami Florida
Teva Investigational Site 10553 Miami Florida
Teva Investigational Site 11508 Miami Florida
Teva Investigational Site 11514 Miami Florida
Teva Investigational Site 11516 Miami Florida
Teva Investigational Site 11530 Miami Florida
Teva Investigational Site 11570 Miami Florida
Teva Investigational Site 10571 Ocala Florida
Teva Investigational Site 11537 Sarasota Florida
Teva Investigational Site 10593 South Miami Florida
Teva Investigational Site 11555 Tallahassee Florida
Teva Investigational Site 10554 Tamarac Florida
Teva Investigational Site 10539 Tampa Florida
Teva Investigational Site 10525 Valrico Florida
Teva Investigational Site 11504 Albany Georgia
Teva Investigational Site 10511 Columbus Georgia
Teva Investigational Site 11510 Columbus Georgia
Teva Investigational Site 11572 Columbus Georgia
Teva Investigational Site 10568 Lawrenceville Georgia
Teva Investigational Site 10586 Lilburn Georgia
Teva Investigational Site 11539 Savannah Georgia
Teva Investigational Site 10543 Stockbridge Georgia
Teva Investigational Site 11558 Indianapolis Indiana
Teva Investigational Site 10527 South Bend Indiana
Teva Investigational Site 10584 Iowa City Iowa
Teva Investigational Site 11501 Overland Park Kansas
Teva Investigational Site 10591 Lexington Kentucky
Teva Investigational Site 11567 Louisville Kentucky
Teva Investigational Site 10513 Metairie Louisiana
Teva Investigational Site 10564 Bangor Maine
Teva Investigational Site 11548 Baltimore Maryland
Teva Investigational Site 10510 Largo Maryland
Teva Investigational Site 10577 Wheaton Maryland
Teva Investigational Site 10538 Brockton Massachusetts
Teva Investigational Site 10546 North Dartmouth Massachusetts
Teva Investigational Site 11502 Troy Michigan
Teva Investigational Site 10531 Plymouth Minnesota
Teva Investigational Site 11562 Columbia Missouri
Teva Investigational Site 11563 Columbia Missouri
Teva Investigational Site 10552 St Louis Missouri
Teva Investigational Site 10575 St Louis Missouri
Teva Investigational Site 10589 St Louis Missouri
Teva Investigational Site 11532 St Louis Missouri
Teva Investigational Site 10518 Bellevue Nebraska
Teva Investigational Site 10550 Omaha Nebraska
Teva Investigational Site 11529 Omaha Nebraska
Teva Investigational Site 11571 Las Vegas Nevada
Teva Investigational Site 10559 Cherry Hill New Jersey
Teva Investigational Site 11566 Edison New Jersey
Teva Investigational Site 10501 Hillsborough New Jersey
Teva Investigational Site 11550 Ocean City New Jersey
Teva Investigational Site 10588 West Orange New Jersey
Teva Investigational Site 11503 Albuquerque New Mexico
Teva Investigational Site 10587 Brooklyn New York
Teva Investigational Site 10520 New York New York
Teva Investigational Site 10532 Newburgh New York
Teva Investigational Site 10567 North Syracuse New York
Teva Investigational Site 10512 Rochester New York
Teva Investigational Site 10580 The Bronx New York
Teva Investigational Site 10522 Canton Ohio
Teva Investigational Site 10507 Cincinnati Ohio
Teva Investigational Site 10523 Cincinnati Ohio
Teva Investigational Site 10544 Columbus Ohio
Teva Investigational Site 11521 Dayton Ohio
Teva Investigational Site 11505 Middleburg Heights Ohio
Teva Investigational Site 10560 Oklahoma City Oklahoma
Teva Investigational Site 10574 Oklahoma City Oklahoma
Teva Investigational Site 10579 Oklahoma City Oklahoma
Teva Investigational Site 11544 Tulsa Oklahoma
Teva Investigational Site 10598 Ashland Oregon
Teva Investigational Site 11543 Medford Oregon
Teva Investigational Site 11557 Portland Oregon
Teva Investigational Site 10509 Altoona Pennsylvania
Teva Investigational Site 10555 Philadelphia Pennsylvania
Teva Investigational Site 10566 Pittsburgh Pennsylvania
Teva Investigational Site 10521 Upland Pennsylvania
Teva Investigational Site 10581 Lincoln Rhode Island
Teva Investigational Site 10562 Providence Rhode Island
Teva Investigational Site 10526 Charleston South Carolina
Teva Investigational Site 11547 Charleston South Carolina
Teva Investigational Site 10583 Orangeburg South Carolina
Teva Investigational Site 10517 Spartanburg South Carolina
Teva Investigational Site 11515 Spartanburg South Carolina
Teva Investigational Site 10519 Boerne Texas
Teva Investigational Site 10541 Dallas Texas
Teva Investigational Site 10542 Dallas Texas
Teva Investigational Site 10548 El Paso Texas
Teva Investigational Site 11552 El Paso Texas
Teva Investigational Site 11512 Fort Worth Texas
Teva Investigational Site 11565 Houston Texas
Teva Investigational Site 11568 Houston Texas
Teva Investigational Site 10515 San Antonio Texas
Teva Investigational Site 10569 San Antonio Texas
Teva Investigational Site 11517 San Antonio Texas
Teva Investigational Site 11519 San Antonio Texas
Teva Investigational Site 11560 Waco Texas
Teva Investigational Site 11528 Layton Utah
Teva Investigational Site 10576 Provo Utah
Teva Investigational Site 10534 South Burlington Vermont
Teva Investigational Site 10502 Fairfax Virginia
Teva Investigational Site 10595 Manassas Virginia
Teva Investigational Site 10508 Richmond Virginia
Teva Investigational Site 11561 Bellingham Washington
Teva Investigational Site 11541 Seattle Washington
Teva Investigational Site 10524 Spokane Washington
Teva Investigational Site 10530 Tacoma Washington
Teva Investigational Site 11511 Tacoma Washington
Teva Investigational Site 10570 Greenfield Wisconsin
Teva Investigational Site 11559 Greenfield Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 152 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01576718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2018 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01576718 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →